Clinical trial

Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer

NCT00284778

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-02-01

PhasePHASE3

Study timeline

Study start (unknown)2006-02-01Date precision: month

Registry last updated2025-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

Alimta®DRUG

Taxotere®DRUG

Sponsors & collaborators

University Hospital, Limogeslead sponsor

Groupe Francais De Pneumo-Cancerologiecollaborator

Mapped research locations

ParisFrance3 RouenFrance2 MarseilleFrance1 LyonFrance1 AngersFrance1 LimogesFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00284778 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.